Winston Partners Speak at The 17th Annual Pharmaceutical Compliance Congress

Winston & Strawn Partner Reed Stephens spoke at Pharmaceutical Compliance Congress (PCC) 2020 August 10-14, 2020. This annual bio/pharma event brings together compliance and legal professionals for the latest in enforcement trends and best practices.

On August 10, Neely participated in the “Invitation-Only CCO and GC Summit.” Reed participated in a panel discussion on August 11 titled “Calling All Emerging Biotechs — Pre-Commercial Compliance Considerations and Checklist.” 

Neely guides leading companies in the United States and around the world through merger review and clearance processes and develops creative strategies for clients contemplating M&A transactions to reduce their antitrust risk. She provides counseling and compliance training on a wide variety of antitrust issues, with particularly significant experience advising companies in the energy and health care sectors.

A nationally-recognized legal authority in the life sciences industry, Reed focuses his practice on pharmaceutical fraud and abuse, corporate compliance, and risk management. He has extensive experience in Anti-Kickback Statute and Stark Physician Self-Referral Law False Claims Act litigation.